S L Silverman
Overview
Explore the profile of S L Silverman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
2251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Silverman S, Nasser K, Nattrass S, Drinkwater B
Osteoporos Int
. 2011 Jul;
23(3):1069-74.
PMID: 21755401
Unlabelled: We examined how the use of bone turnover markers and educational information affects persistence of bisphosphonate use in osteoporotic patients. We found that reporting bone turnover results and/or educational...
12.
Solimeo S, Silverman S, Calderon A, Nguyen A, Gold D
Osteoporos Int
. 2011 Apr;
23(3):841-52.
PMID: 21528362
Unlabelled: The Male Osteoporosis Assessment Questionnaire (OPAQ™) is a health-related quality of life (HRQOL) instrument that can differentiate between men with and without fracture. The Male OPAQ™ is a reliable...
13.
Silverman S, Kriegman A, Goncalves J, Kianifard F, Carlson T, Leary E
Osteoporos Int
. 2010 Dec;
22(8):2337-45.
PMID: 21116816
Unlabelled: A randomized, double-blind, placebo-controlled study assessed the efficacy of acetaminophen or fluvastatin in preventing post-dose symptoms (increases in body temperature or use of rescue medication) following a single infusion...
14.
Silverman S, Schousboe J, Gold D
Osteoporos Int
. 2010 May;
22(1):21-6.
PMID: 20458571
Compliance to oral bisphosphonates is suboptimal, with negative consequences of increased healthcare utilization and less effective fracture risk reduction. Extending dose interval increased adherence only moderately. We used literature derived...
15.
Harris S, Reginster J, Harley C, Blumentals W, Poston S, Barr C, et al.
Bone
. 2009 Jan;
44(5):758-65.
PMID: 19168160
The eValuation of IBandronate Efficacy (VIBE) head-to-head database fracture study compared fracture rates between patients treated with monthly ibandronate and weekly oral bisphosphonates (BPs). This large study included women >/=45...
16.
Binkley N, Silverman S, Simonelli C, Santiago N, Kohles J, Dasic G, et al.
Osteoporos Int
. 2009 Jan;
20(9):1595-601.
PMID: 19145396
Unlabelled: Bone turnover markers such as serum C-terminal cross-linking telopeptide of type I collagen (CTX-I) can be used to assess drug efficacy in osteoporosis. This study evaluated the pattern of...
17.
Cramer J, Gold D, Silverman S, Lewiecki E
Osteoporos Int
. 2007 Feb;
18(8):1023-31.
PMID: 17308956
Unlabelled: Fourteen reports utilizing data from de-identified administrative databases were reviewed. Studies contained at least one measure of patient persistence or compliance with bisphosphonates or bisphosphonates and other anti-osteoporosis medications....
18.
Silverman S, Watts N, Delmas P, Lange J, Lindsay R
Osteoporos Int
. 2006 Nov;
18(1):25-34.
PMID: 17106785
Introduction: Randomized clinical trials have shown that risedronate and alendronate reduce fractures among women with osteoporosis. The aim of this observational study was to observe, in clinical practice, the incidence...
19.
Zingmond D, SooHoo N, Silverman S
Osteoporos Int
. 2006 Jun;
17(10):1562-8.
PMID: 16775669
Introduction: The impact of socioeconomic status-income and acculturation-on hip fracture is not well understood. We studied 116,919 fractures among 8,144,469 people in California. Greater income and English fluency predict lower...
20.
Reginster J, Adami S, Lakatos P, Greenwald M, Stepan J, Silverman S, et al.
Ann Rheum Dis
. 2005 Dec;
65(5):654-61.
PMID: 16339289
Background: Reducing bisphosphonate dosing frequency may improve suboptimal adherence to treatment and therefore therapeutic outcomes in postmenopausal osteoporosis. Once-monthly oral ibandronate has been developed to overcome this problem. Objective: To...